Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1981 Mar 7;282(6266):761–762.

Penicillamine nephropathy.

PMCID: PMC1504574  PMID: 6783160

Full text

PDF
761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos H. Detection of antibodies in penicillamine sensitivity. Postgrad Med J. 1968 Oct;(Suppl):27–30. [PubMed] [Google Scholar]
  2. Bacon P. A., Tribe C. R., Mackenzie J. C., Verrier-Jones J., Cumming R. H., Amer B. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Q J Med. 1976 Oct;45(180):661–684. [PubMed] [Google Scholar]
  3. Batsford S. R., Rohrbach R., Riede U. N., Sandritter W., Kluthe R. Effects of D-penicillamine administration to rats, induction of renal changes: preliminary communication. Clin Nephrol. 1976 Sep;6(3):394–397. [PubMed] [Google Scholar]
  4. Dische F. E., Swinson D. R., Hamilton E. B., Parsons V. Immunopathology of penicillamine-induced glomerular disease. J Rheumatol. 1976 Jun;3(2):145–154. [PubMed] [Google Scholar]
  5. Friedman R., Gallo G. R., Buxbaum J. N. Renal disease in rheumatoid arthritis. Arthritis Rheum. 1980 Jun;23(6):781–783. doi: 10.1002/art.1780230614. [DOI] [PubMed] [Google Scholar]
  6. GOLDBERG A., SMITH J. A., LOCHHEAD A. C. Treatment of lead-poisoning with oral penicillamine. Br Med J. 1963 May 11;1(5340):1270–1275. doi: 10.1136/bmj.1.5340.1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gibson T., Burry H. C., Ogg C. Letter: Goodpasture syndrome and D-penicillamine. Ann Intern Med. 1976 Jan;84(1):100–100. doi: 10.7326/0003-4819-84-1-100_1. [DOI] [PubMed] [Google Scholar]
  8. Hill H. F., Hill A. G., Day A. T., Brown R. M., Golding J. R., Lyle W. H. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen. Ann Rheum Dis. 1979 Oct;38(5):429–433. doi: 10.1136/ard.38.5.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hill H., Hill A., Davison A. M. Resumption of treatment with penicillamine after proteinuria. Ann Rheum Dis. 1979 Jun;38(3):229–231. doi: 10.1136/ard.38.3.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jellum E., Aaseth J., Munthe E. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same? Proc R Soc Med. 1977;70 (Suppl 3):136–139. doi: 10.1177/00359157770700S341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karp M., Lurie M., Yonis Z. Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine. Arch Dis Child. 1966 Dec;41(220):684–687. doi: 10.1136/adc.41.220.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Luke R. G., Briggs J. D., Fell G. S., Kennedy A. C. Proteinuria associated with D-penicillamine therapy of cystinuria. J Urol. 1968 Feb;99(2):207–210. doi: 10.1016/S0022-5347(17)62675-2. [DOI] [PubMed] [Google Scholar]
  13. Lyle W. H., Green J. N., Gore V., Vidler J. Enhancement of cadmium nephrotoxicity by penicillamine in the rat. Postgrad Med J. 1968 Oct;(Suppl):18–21. [PubMed] [Google Scholar]
  14. Neild G. H., Gärtner H. V., Bohle A. Penicillamine induced membranous glomerulonephritis. Scand J Rheumatol Suppl. 1979;(28):79–90. doi: 10.3109/03009747909108243. [DOI] [PubMed] [Google Scholar]
  15. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rosenberg L. E., Hayslett J. P. Nephrotoxic effects of penicillamine in cystinuria. JAMA. 1967 Aug 28;201(9):698–699. [PubMed] [Google Scholar]
  17. Ross J. H., McGinty F., Brewer D. G. Penicillamine nephropathy. Nephron. 1980;26(4):184–186. doi: 10.1159/000181984. [DOI] [PubMed] [Google Scholar]
  18. Stephens A. D., Watts R. W. The treatment of cystinuria with N-acetyl-D-penicillamine, a comparison with the results of D-penicillamine treatment. Q J Med. 1971 Jul;40(159):355–370. [PubMed] [Google Scholar]
  19. Sternlieb I., Bennett B., Scheinberg I. H. D-penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med. 1975 May;82(5):673–676. doi: 10.7326/0003-4819-82-5-673. [DOI] [PubMed] [Google Scholar]
  20. Sternlieb I. Penicillamine and the nephrotic syndrome. JAMA. 1966 Dec 19;198(12):1311–1312. [PubMed] [Google Scholar]
  21. Zilko P. J., Dawkins R. L., Cohen M. L. Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune status. Proc R Soc Med. 1977;70 (Suppl 3):118–122. doi: 10.1177/00359157770700S336. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES